Abstract
Pancreatic carcinoma remains one of the most challenging malignant tumor with an increasing morbidity in China. The significance of multidisciplinary and comprehensive treatment of pancreatic cancer has been recognized in recent years. Moreover, several novel clinical staging standards of pancreatic cancer have emerged to help optimize the treatment stra-tegies and improve patients’ prognosis in precise treatment era. Currently, in addition to the traditional TNM stage, usage of histologic grade (G), resection marginstatus (M), lymphatic invasion status (L), vascular invasion status (V), perineurial invasion status (P) and combination of these stages recommended by NCCN guideline as GTNMLVP stage have emerged. Other novel staging standards include respectability status, standardized pancreatic surgery classification, genetics classification, etc. This review summarized the characteristics and clinical significance of these novel established methods for pancreatic cancer precise staging. Key words: Pancreatic carcinoma, staging; Borderline resectability status; GTNMLVP stage; Standardized pancreatic surgery classification; Genetics classification
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
